Not going to happen. She's been on the advisory board, if you want to call it that, for a long time. Not one of the advisors have done squat for the company and none will going forward.
That's an UNDENIABLE FACT.
Interesting fact is that Helen's company Preceden (formally intrexon) bought out Thomas Ichim's company Medistem back in 2013.